Connect with us

Technology

Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics’ Single Cell Genomics Sequencing Technology

Published

2 years ago

on

Gene structure information identified by combining Compugen’s AI/ML predictive computational discovery platform, Unigen™ with Ultima’s UG 100™ sequencing platform to better understand tumor biology and immune regulationLeveraging Compugen’s computational analytical tools uncovered high consistency in single-cell expression levels across Ultima’s UG 100 sequencing platform, offering a potential advantage for demarcation of transcript termination.Research presented at Advances in Genome Biology and Technology (AGBT) 2025 General Meeting

HOLON, Israel, Feb. 26, 2025 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced results generated in a joint research collaboration, combining Compugen’s AI/ML powered predictive computational discovery platform, Unigen, with high throughput single cell sequencing on Ultima’s UG 100 to uncover new insights on gene structure for immuno-oncology.

“We are excited to collaborate with Ultima Genomics, a pioneer in next generation gene sequencing, to enhance our proprietary gene sequencing database, which is part of our Unigen platform,” said Eran Ophir, Ph.D., Chief Scientific Officer at Compugen. “We developed algorithms to study gene splicing in single cell resolution and applied it to analyze patient tumor samples to uncover new potential regulatory mechanisms in immuno-oncology. Some of the findings were presented at the AGBT conference. Compugen plans to further harness Ultima’s technology to develop its proprietary single cell atlases for accelerated discovery of new immunotherapies.”

“We are excited to support Compugen’s capabilities in predictive computational discovery of new drug targets and development of new cancer immunotherapies,” said Gilad Almogy, Founder and CEO of Ultima Genomics. “We built our innovative sequencing architecture and our UG 100 sequencing platform to enable researchers to unlock new applications and insights through lower cost sequencing and more omics data. The successful outcome of our collaboration with Compugen is a great example of an application that is data-starved due to the constraints of conventional sequencing technology and can be transformed through large scale data and AI/ML techniques. Single cell sequencing is also an excellent fit for our technology which is now compatible with the leading library prep technologies.”

Dr. Roy Granit, Head of Computational Discovery at Compugen is the lead author on a poster presented by Ultima Genomics at the Advances in Genome Biology and Technology (AGBT) 2025 general meeting on February 25, 2025, in Marco Island, Florida. 

Poster presentation details:

Title: Using 3′ Single Cell Sequencing to Study Patient-Derived Tumor Cells Reveals Enhanced Potential to Study Differential Splicing at the Cell Type Level
Poster number: 224
Date and time: Tuesday, February 25, 4:45 p.m. – 6:10 p.m. ET
Leading author: Roy Granit, Ph.D., Director, Head of Computational Discovery, Compugen, Israel
Presenter: Zohar Shipony, Ph.D. Ultima Genomics, United States

Key Findings:

Comparative analysis using tumor samples from cancer patients, found high consistency in single-cell expression levels across Ultima Genomics’ UG 100 and Illumina’s Novaseq 6000 sequencing platforms.UG 100 offers clearer demarcation of 3′ mRNA transcript end and provides a unique opportunity to study gene structure, which can potentially be harnessed to better understand tumor biology and immune regulation. Gene structure information identified in this approach is contributing to the predictive models of Unigen.

The poster is available on the publications section of Compugen’s website, www.cgen.com.

About Unigen™

Compugen has been at the forefront of decoding cancer biology, with its AI/ML powered predictive computational discovery platform, recently branded as Unigen™. Unigen is Compugen’s code-to-cure, flexible-loop platform for the computational prediction of novel drug target discovery and development of cancer immunotherapy. Unigen combines Compugen’s deep scientific knowledge, AI/ML predictive algorithms and a cloud-based, technology-agnostic platform integrating a variety of biological data such as multi-omics, single-cell RNA sequencing and spatial omics data. The outcomes from Compugen’s preclinical and clinical trials enrich the proprietary knowledgebase to discover additional novel drug targets and further understand complex biology. To date, Unigen has yielded multiple novel immuno-oncology drug targets, potential first- or best-in-class clinical stage immuno-oncology programs, validating partnerships with multiple pharmaceutical companies and undisclosed programs in its early-stage pipeline.

About Compugen

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery platform (Unigen™) to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has two proprietary product candidates in Phase 1 development: COM701, a potential first-in-class anti-PVRIG antibody and COM902, a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors. Rilvegostomig, a PD-1/TIGIT bispecific antibody where the TIGIT component is derived from Compugen’s clinical stage anti-TIGIT antibody, COM902, is in Phase 3 development by AstraZeneca through a license agreement for the development of bispecific and multispecific antibodies. GS-0321 (previously COM503), a potential first-in-class, high affinity anti-IL-18 binding protein antibody, which is in Phase 1 development is licensed to Gilead. In addition, the Company’s therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance. Compugen is headquartered in Israel, with offices in San Francisco, CA. Compugen’s shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN.

Forward-Looking Statement

This press release contains “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended, and the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the current beliefs, expectations, and assumptions of Compugen. Forward-looking statements can be identified using terminology such as “will,” “may,” “expects,” “anticipates,” “believes,” “potential,” “plan,” “goal,” “estimate,” “likely,” “should,” “confident,” and “intends,” and similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements include, but are not limited to, statement regarding Ultima’s UG 100™ sequencing platform offering a potential advantage for demarcation of transcript termination and statements regarding Compugen’s plans to further harness Ultima’s technology to develop its proprietary single cell atlases for accelerated discovery of new immunotherapies. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance, or achievements of Compugen to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Among these risks: the clinical trials of any product candidates that Compugen, or any current or future collaborators, may develop may fail to satisfactorily demonstrate safety and efficacy to the FDA, and Compugen, or any collaborators, may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of these product candidates; Compugen’s business model is substantially dependent on entering into collaboration agreements with third parties and Compugen may not be successful in generating adequate revenues or commercializing aspects of its business model; Compugen’s approach to the discovery of therapeutic products is based on its proprietary computational target discovery infrastructure, which is unproven clinically; general market, political and economic conditions in the countries in which Compugen operates, including Israel; the effect of the evolving nature of the recent war in Gaza; and Compugen does not know whether it will be able to discover and develop additional potential product candidates or products of commercial value. These risks and other risks are more fully discussed in the “Risk Factors” section of Compugen’s most recent Annual Report on Form 20-F as filed with the Securities and Exchange Commission (SEC) as well as other documents that may be subsequently filed by Compugen from time to time with the SEC. In addition, any forward-looking statements represent Compugen’s views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Compugen does not assume any obligation to update any forward-looking statements unless required by law.

Compugen contact:
Yvonne Naughton, Ph.D.
VP, Head of Investor Relations, and Corporate Communications
Email: ir@cgen.com
Tel: +1 (628) 241-0071 

 

View original content:https://www.prnewswire.com/news-releases/compugen-enhances-its-aiml-predictive-computational-discovery-platform-unigen-with-ultima-genomics-single-cell-genomics-sequencing-technology-302385891.html

SOURCE Compugen Ltd.

Related Topics:
Continue Reading

Technology

Sapient Insights Group Reveals the HR Technology Solutions Ranking Highest in Vendor Satisfaction and User Experience for 2026

Published

30 minutes ago

on

October 21, 2026

By

Voice of the Customer badges awarded across 23 HR technology categories, based on 10,000 responses to Sapient’s 2026-2027 Annual HR Systems Survey

LAS VEGAS, Oct. 21, 2026 /PRNewswire-PRWeb/ — Sapient Insights Group today revealed the HR technology solutions ranking highest in vendor satisfaction and user experience in its 2026-2027 HR Systems Survey, now in its 29th year. This year Sapient awarded 630 Voice of the Customer badges across 23 technology categories and three company sizes. The rankings are based on responses from HR professionals representing 6,038 organizations.

Stacey Harris, Chief Research Officer and Managing Partner at Sapient Insights Group, presents the HR technology solutions ranking highest in vendor satisfaction and user experience for 2026.

To help buyers find the providers that fit their organization, the rankings are split into three company sizes: small, mid-sized, and enterprise. Respondents rate their satisfaction with their current solution in each technology category on a scale of 1 to 5, with attention to support and service. Sapient also ranks solutions on user experience. The top five solutions in each category and size earn a badge for vendor satisfaction and a badge for user experience. Three categories with smaller sample sizes (Time Labor Budgeting, Contingent Workforce Management, and Skills Management) are ranked in aggregate across all company sizes.

The survey continues to grow with the HR technology market. New this year, the survey adds Compliance Management to the HR Blueprint, application-level outcome questions, payment models for applications and AI, and finance applications covering Core, Expense, and Planning. It also asks more “why” questions throughout, so the results show not just what organizations are doing but the reasons behind their choices.

“Our Voice of the Customer rankings come straight from HR practitioners, with no sponsorship involved, which is why buyers and vendors both pay attention to them,” said Stacey Harris, chief research officer and managing partner at Sapient Insights Group. “This year we expanded the rankings to cover more of the HR technology landscape, which gives buyers a clearer view of how solutions perform for the specific work they need done, not just at the suite level. It also gives vendors honest feedback from the people who use their products every day.”

The highest-ranking solutions for vendor satisfaction are listed below. Rankings include point solutions, modules within technology suites, and in some cases service providers.

Payroll
Dayforce – Enterprise
isolved – Mid-sized
BambooHR – Small

HR Management
Dayforce – Enterprise
HiBob – Mid-sized
BambooHR – Small

Benefits
Businessolver – Enterprise
Fidelity NetBenefits/PSW – Mid-sized
HiBob – Small

HR Service Delivery: Portal
Dovetail – Enterprise
Workday Help – Mid-sized
isolved – Small

HR Service Delivery: Content Management
Dovetail – Enterprise
DocuSign – Mid-sized
isolved – Small

HR Service Delivery: Employee Help Desk
Dovetail – Enterprise
ServiceNow – Mid-sized
isolved – Small

HR Service Delivery: Engagement Survey
Dovetail – Enterprise
isolved – Mid-sized
BambooHR – Small

Time and Attendance
Darwinbox – Enterprise
isolved – Mid-sized
isolved – Small

Absence Management
Darwinbox – Enterprise
isolved – Mid-sized
BambooHR – Small

Leave Management
Darwinbox – Enterprise
isolved – Mid-sized
isolved – Small

Workforce Scheduling
Darwinbox – Enterprise
isolved – Mid-sized
isolved – Small

Labor Budgeting
isolved – All sizes

Learning
Cornerstone – Enterprise
OpenSesame – Mid-sized
isolved – Small

Recruiting
Indeed – Enterprise
Greenhouse – Mid-sized
BambooHR – Small

Onboarding
Dayforce – Enterprise
isolved (ApplicantPro) – Mid-sized
BambooHR – Small

Performance
Dayforce – Enterprise
HiBob – Mid-sized
BambooHR – Small

Compensation
Dayforce – Enterprise
Payscale Payfactors – Mid-sized
Insperity – Small

Succession
Dayforce – Enterprise
Microsoft Glint – Mid-sized
Paylocity – Small

Rewards and Recognition
Awardco – Enterprise
isolved – Mid-sized
Gifted – Small

Analytics
Visier – Enterprise
Visier – Mid-sized
UKG People Analytics – Small

AI/ML
Visier Vee – Enterprise
Grammarly – Mid-sized
Anthropic Claude – Small

Contingent Workforce Management
ServiceNow – All sizes

Skills Management HiBob – All sizes

The complete Voice of the Customer results, including the top five solutions for vendor satisfaction and user experience in every category and company size, are available here (https://sapientinsights.com/top-vendors/).

Sapient Insights Group will publish detailed survey findings and analysis in its annual HR Systems Research Report on November 6, 2026. The report will be available to purchase here (https://sapientinsights.com/shop/).

About the 2026-2027 HR Systems Survey

Now in its 29th year, Sapient’s HR Systems Survey is the longest-running, most comprehensive survey of the HR technology landscape, and the only fully objective, non-sponsored study of its kind. This year, HR professionals representing 6,038 organizations around the globe took part. The survey now covers 23 technology categories. The annual report includes an in-depth look at each category, along with current and future adoption rates, customer retention, replacement plans, and projected vendor growth.

For more information about the survey and report, schedule a call (https://calendly.com/summerorellano/schedule-a-call-with-sapient-insights-group).

About Sapient Insights Group Sapient Insights Group is a certified women-owned, privately-owned consulting, research, and advisory firm. The company works with organizations in the areas of HR and finance technology; HR strategy and transformation; leadership and culture; change management; talent management; mergers and acquisitions; and project management. The company’s HR Systems Survey is the HR profession’s most trusted source for objective data on the HR technology market and insights to guide buyer investments and vendor product development and marketing. For more information, visit www.sapientinsights.com.

Media Contact

Allison Williams, Sapient Insights Group, 1 4043044748, Info@sapientinsights.com, https://sapientinsights.com/

View original content to download multimedia:https://www.prweb.com/releases/sapient-insights-group-reveals-the-hr-technology-solutions-ranking-highest-in-vendor-satisfaction-and-user-experience-for-2026-302915884.html

SOURCE Sapient Insights Group

Continue Reading

Technology

SAJ Debuts First CEC-Approved Systems under Australia’s New Battery Standard at All Energy 2026

Published

30 minutes ago

on

October 21, 2026

By

EK70 HS5 and EK90 HS5 on show at Stand M143, with Australia’s Strongest Man at Stand E01 and the SAJ range across three distributor stands

MELBOURNE, Australia, Oct. 22, 2026 /PRNewswire/ — SAJ will exhibit at All Energy Australia 2026 at the Melbourne Convention and Exhibition Centre on 28–29 October. At Stand M143, installers can get their first hands-on look at the EK70 HS5 and EK90 HS5, the first products approved under Australia’s new SA TS 5398 standard.

At 2pm on Wednesday 28 October, DEKRA and CCS will present SAJ with the CEC certificates for the EK70 HS5 and EK90 HS5 on the stand, making SAJ the first brand listed under SA TS 5398. SAJ and DEKRA will also sign a strategic cooperation agreement covering safety, quality and compliance.

On the stand

EK70 HS5 – the all-in-one home energy system, combining hybrid inverter, LFP battery and whole-home backup in one unit. Modular 6, 7 and 9 kWh battery blocks stack to suit the household.EK90 HS5 – the premium tier, with 12,000-cycle cells, nine-layer safety protection, edge AI and a 15-year warranty.B2S and H2 – modular storage and the latest from SAJ’s residential range.elekeeper 5.0 – SAJ’s energy management app, with AI-assisted design, five-minute app commissioning and remote diagnosis.C&I – SAJ’s latest commercial and industrial solutions.

Live demonstrations of the EK70 HS5 and EK90 HS5, elekeeper 5.0 and the C&I range run at 10am on both days and again at 3pm on Wednesday.

Visitors can also play the claw machine on the stand throughout both days to win tennis balls signed by SAJ brand ambassador Alex de Minaur.

Beat Australia’s Strongest Man of 2026 at Stand E01

At Stand E01, near the hall entrance, visitors can take on Bradman Houston, Australia’s Strongest Man 2026, on the high striker. Bradman will be there each day. Anyone who beats his score wins!

Bradman recently partnered with SAJ and Sydney Solar & Electrical on a video series about lifting technique and fitness for solar installers, now on SAJ’s Instagram.

SAJ across the floor

The SAJ range is also on show with the company’s three national distribution partners, for stock, pricing and account conversations:

One Stop Warehouse – Stand EE113, with the EK90 HS5 on displaySupply Partners – Stand L135Tradezone – Stand S113

“All Energy is where the industry sees what’s next, and for SAJ that’s the EK70 HS5 and EK90 HS5,” said Alan Li, the Sales Director of SAJ Electric Australia. “Installers told us they want one integrated system that’s faster to install and that they can stand behind. Being the first brand listed under SA TS 5398 is the proof. We’d love installers to see both systems up close at Stand M143, and to try their luck against Bradman at E01 while they’re there.”

Visit SAJ

Where: Stand M143 (Beat the Strongest Man at Stand E01), Melbourne Convention and Exhibition CentreWhen: Wednesday 28 – Thursday 29 October 2026More information: au.saj-electric.com

About SAJ

Founded in Guangzhou in 2005, SAJ (Guangzhou Sanjing Electric Co., Ltd.) is a specialist in smart energy storage, delivering integrated solutions across solar generation, battery storage, energy management and EV charging for residential and commercial customers. SAJ has operated in Australia since 2013 and works with three national distribution partners – One Stop Warehouse, Supply Partners and Tradezone – backed by local technical support and warranty infrastructure.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/saj-debuts-first-cec-approved-systems-under-australias-new-battery-standard-at-all-energy-2026-302915502.html

SOURCE SAJ

Continue Reading

Technology

Starvia Automotive Expands Used-Car Exports to Afghanistan and Iran

Published

31 minutes ago

on

October 21, 2026

By

GUANGZHOU, China, Oct. 22, 2026 /PRNewswire/ — Starvia Automotive has added Afghanistan and Iran to the destinations covered by its used-car export business, the company said on Oct. 21, as it focuses on used vehicles built to Chinese-market specifications. Buyers in both markets can now request an assessment of a specific vehicle before an order is confirmed.

What the review covers

For a used vehicle, the model name alone does not determine whether an export order can proceed. Year of manufacture, vehicle identity, condition, ownership documents and destination import rules are reviewed for each request, together with carrier acceptance, transit requirements and payment restrictions, according to the company.

Starvia cited two listings in its online used-car catalog as examples of the process: a 2023 Volkswagen Polo and a 2021 Volkswagen Tharu. The company said the listings show published stock and do not confirm that either unit is available or eligible for import into both markets. Stock, vehicle records and destination suitability are confirmed before a model is presented as an order option.

How an inquiry is handled

Inquiries are submitted through the company’s online form, which asks for destination city, importer details, preferred vehicle, quantity and purchasing timeframe. Starvia said the information is used to identify suitable vehicles, check documentation and seek a transport option, and that alternatives can be discussed if the first model does not meet the requirements.

An Arabic-language version of the site is available at https://www.starviaauto.com/ar?utm_source=prnews for buyers who prefer Arabic.

Any vehicle offer, freight estimate or shipment timing remains subject to commercial, regulatory and logistics checks, the company said. Buyers should obtain destination-side import approval before committing to a purchase.

About Starvia Automotive

Starvia Automotive is a Guangzhou-based exporter of new and used vehicles. Its online catalog lists used cars with vehicle history and inspection information for buyers in multiple regions.

View original content:https://www.prnewswire.co.uk/news-releases/starvia-automotive-expands-used-car-exports-to-afghanistan-and-iran-302915298.html

Continue Reading

Trending